 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| Chemical and physical data | |
| Formula | C15H22N2 |
| Molar mass | 230.355 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 71 to 73 °C (160 to 163 °F) |
| |
| |
| (verify) | |
Ethylisopropyltryptamine (EiPT) is a chemical of thetryptamine family that and producespsychedelic andhallucinogenic effects. It was probably first synthesized by Americanpsychopharmacologist,Alexander Shulgin.
EiPT is short forN-ethyl-N-isopropyl-tryptamine. The full chemical name of this structure is N-ethyl-N-[2-(1H-indol-3-yl)ethyl]propan-2-amine. EiPT is a tryptamine, which all belong to a larger family of compounds known asindolethylamines. EiPT is closely related to the compoundsdiethyltryptamine (DET) andDIPT.
In his bookTiHKAL, Alexander Shulgin lists a dosage for EiPT as being 24-40mg takenorally.
Very little is known about thepsychopharmacological properties of EiPT, but reports suggest it produces psychedelic effects that can last 4–6 hours. According to Shulgin, this compound tends to producenausea,dysphoria, and other unpleasant side-effects. It also lacks the hallucinatory and visual properties usually associated with psychedelic drugs.
There have been no reported deaths or hospitalizations from EiPT, but its safety profile is unknown.
EiPT is unscheduled and uncontrolled in the United States, but possession and sales of EiPT could be prosecuted under theFederal Analog Act because of its structural similarities to DET.
